Eleview® is a novel, ready to use, submucosal injectable composition that upon injection forms an immediate cushion of optimal shape, height, and duration and was designed for use in the safe and easy removal of polyps, adenomas, early stage cancers, and other lesions in the gastrointestinal (GI) tract.
Eleview is appropriate for challenging polyps, regardless of size, location, or type and the immediate, long-lasting cushion can hold for up to 45 minutes. Eleview improves margin visualization and helps decrease the risk of gastrointestinal perforation and damage to the external muscular layer, which can lead to gastrointestinal perforation. Furthermore, it may decrease the time needed to resect a lesion while reducing both reinjections required and piecemeal excisions, as compared to other submucosal injection agents, like Saline.
Eleview is FDA 510(k) cleared as a Class II medical device and was launched in the US in May 2017.